Literature DB >> 22252891

Toward a redefinition of Parkinson's disease.

Matthew B Stern1, Anthony Lang, Werner Poewe.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22252891     DOI: 10.1002/mds.24051

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  42 in total

Review 1.  Precision medicine for disease modification in Parkinson disease.

Authors:  Alberto J Espay; Patrik Brundin; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

Review 2.  Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Authors:  J A Obeso; M Stamelou; C G Goetz; W Poewe; A E Lang; D Weintraub; D Burn; G M Halliday; E Bezard; S Przedborski; S Lehericy; D J Brooks; J C Rothwell; M Hallett; M R DeLong; C Marras; C M Tanner; G W Ross; J W Langston; C Klein; V Bonifati; J Jankovic; A M Lozano; G Deuschl; H Bergman; E Tolosa; M Rodriguez-Violante; S Fahn; R B Postuma; D Berg; K Marek; D G Standaert; D J Surmeier; C W Olanow; J H Kordower; P Calabresi; A H V Schapira; A J Stoessl
Journal:  Mov Disord       Date:  2017-09       Impact factor: 10.338

Review 3.  Advances in markers of prodromal Parkinson disease.

Authors:  Ronald B Postuma; Daniela Berg
Journal:  Nat Rev Neurol       Date:  2016-10-27       Impact factor: 42.937

Review 4.  Different diagnostic criteria for Parkinson disease: what are the pitfalls?

Authors:  Roongroj Bhidayasiri; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2013-03-15       Impact factor: 3.575

Review 5.  Parkinson disease: an update.

Authors:  Steven J Frucht
Journal:  Neurologist       Date:  2004-07       Impact factor: 1.398

Review 6.  Is there a need to redefine Parkinson's disease?

Authors:  Philipp Mahlknecht; Werner Poewe
Journal:  J Neural Transm (Vienna)       Date:  2013-05-29       Impact factor: 3.575

7.  Risk factors and prodromal markers and the development of Parkinson's disease.

Authors:  Stefanie Lerche; Klaus Seppi; Stefanie Behnke; Inga Liepelt-Scarfone; Jana Godau; Philipp Mahlknecht; Alexandra Gaenslen; Kathrin Brockmann; Karin Srulijes; Heiko Huber; Isabel Wurster; Heike Stockner; Stefan Kiechl; Johann Willeit; Arno Gasperi; Klaus Fassbender; Werner Poewe; Daniela Berg
Journal:  J Neurol       Date:  2013-11-05       Impact factor: 4.849

8.  Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.

Authors:  Avner Thaler; Anat Mirelman; Tanya Gurevich; Ely Simon; Avi Orr-Urtreger; Karen Marder; Susan Bressman; Nir Giladi
Journal:  Neurology       Date:  2012-08-22       Impact factor: 9.910

9.  α-Synuclein in cutaneous autonomic nerves.

Authors:  Ningshan Wang; Christopher H Gibbons; Jacob Lafo; Roy Freeman
Journal:  Neurology       Date:  2013-10-02       Impact factor: 9.910

Review 10.  Characterizing Premotor Parkinson's Disease: Clinical Features and Objective Markers.

Authors:  Lama M Chahine; Matthew B Stern
Journal:  Mov Disord Clin Pract       Date:  2014-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.